Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “azithromycin” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 12
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 12 pipeline programs matching "azithromycin" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

12 results for “azithromycin” Back to intelligence hub

Search results

  1. Azithromycin

    Cardiff Oncology

    Bronchopulmonary Dysplasia

    phase 3 small molecule terminated

    1 trial
  2. Azithromycin plus hydroxychloroquine

    Iterum Therapeutics plc

    Respiratory Tract Infection Viral

    phase 3 small molecule terminated

    1 trial
  3. azithromycin SR (Zithromax; compound: CP-62,993)

    Pfizer

    Bronchitis, Chronic

    phase 3 small molecule completed

    1 trial
  4. azithromycin sustained release

    Pfizer

    Pneumonia

    phase 3 small molecule completed

    1 trial
  5. Sertraline+Antibiotic (penicillin/azithromycin)

    CNS Pharmaceuticals

    Pandas

    phase 2 small molecule terminated

    1 trial
  6. Azithromycin

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial
  7. Azithromycin 600 mg Tablet

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials
  8. Azithromycin Pill

    Arrowhead Pharmaceuticals Ireland Limited

    Infections

    phase 1 small molecule active

    1 trial
  9. Azithromycin

    United Therapeutics Europe Ltd

    Typhoid Fever

    approved small molecule completed

    1 trial
  10. Azithromycin Pill

    United Therapeutics Europe Ltd

    Chronic Obstructive Pulmonary Disease

    approved small molecule active

    1 trial
  11. Azithromycin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bronchiectasis

    small molecule completed

    1 trial
  12. Azithromycin

    United Therapeutics Europe Ltd

    Malnutrition in Pregnancy

    small molecule active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.